SEC Search Search From : Home > Search > Search Results search: Public Information System Debenture Prospectus ( 1,293 ) Equity Prospectus ( 418 ) List of Approved persons / Licensees ( 188

SEC Search Search คุณอยู่ที่ : หน้าแรก > Search > Search Results search: ข้อมูลระบบงานเผยแพร่ Debenture Prospectus ( 1,293 ) Equity Prospectus ( 418 ) List of Approved persons / Licensees ( 188

Public Co., Ltd. would like to submit the financial statement of the Company and subsidiary companies for the year 2017 and present the details of the performance of the Company as follows: 2017 was the

LIABILITIES 697.19 799.92 (102.73 ) (12.84%) TOTAL SHAREHOLDER EQUITY 239.01 401.89 (162.88 ) (40.53%) At the year ended of 2019, company and subsidiaries had less total assets than last year 2018 at Baht

debt to equity ratio 0.35 times, shown that its sufficient liquidity and strong financial position. Please be informed accordingly, Yours Sincerely, DOD Biotech Public Company Limited (Miss Suwarin

consolidated financial statements of the Company and its subsidiaries for the year ended 31st December 2019. In 2019, the Company achieved consolidated profits (attributable to equity holders of the parent) of

Exchange of Thailand Oishi Group Public Company Limited and subsidiaries clarify consolidated operating results and consolidated financial statements for 2017, ended September 30, 2017 as the followings

(attributable to equity holders of the parent) for the same periods of the previous year of Baht 127 million and Baht 352 million respectively. The Company would like to clarify the significant reasons for the

%, compared to the consolidated net profits (attributable to equity holders of the parent) for the same period of the previous year of Baht 198 million and Baht 551 million respectively. The Company would like

Public Company Limited and its subsidiaries (“the Company”) would like to clarify herewith the financial position and operating result for the 3-month period ended 31 March 2020 as follows:- Financial